期刊文献+

多发性骨髓瘤患者骨桥蛋白升高的意义

原文传递
导出
摘要 广泛的溶骨性骨质破坏为多发性骨髓瘤(MM)特征性临床表现。这种骨质破坏的产生不仅与浆细胞的增殖或浸润有关,更与破骨细胞的激活有关。但其确切发病机制仍不清楚。骨桥蛋白(OPN)是一种分泌型磷酸化糖蛋白,在骨组织中与羟基磷灰石晶核结合并以基质沉淀形式存在。近来研究发现OPN在某些骨吸收病理状态下如类风湿关节炎、绝经后骨质疏松等起明显作用。
出处 《中华血液学杂志》 CAS CSCD 北大核心 2009年第4期268-269,共2页 Chinese Journal of Hematology
  • 相关文献

参考文献9

  • 1Gravallese EM. Osteopontin: a bridge between bone and the immune system. J Clin Invest, 2003, 112 : 147-149.
  • 2Yumoto K, Ishigami M, Rittling SR, et al. Osteopontin deficiency protects joints against destruction in anti-type Ⅱ collagen antibody induced arthritis in mice. Proc Natl Acad Sci U S A, 2002, 99: 4556-4561.
  • 3Dizdar O, Barista I, Kalyoncu U, et al. Biochemical markers of bone turnover in diagnosis of myeloma bone disease. Am J Hematol, 2007, 82:185-91.
  • 4黄仲夏,刘晋伟,郭益群,陆敏秋,张蕾,陈文明,戴红,陈世伦.多发性骨髓瘤患者巨噬细胞感染蛋白1α表达的研究[J].中华血液学杂志,2006,27(10):699-700. 被引量:5
  • 5Saeki Y, Mima T, Ishii T, et al. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications. Br J Haematol, 2003, 123:263-270.
  • 6Standal T, Hjorth-Hansen H, Rasmussen T , et al. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica, 2004, 89 : 174-182.
  • 7Caers J, Gunthert U, de Raeve H, et al. The involvement of osteopontin and its receptors in multiple myeloma cell survival, migration and invasion in the murine 5T33MM model. Br J Haematol, 2006, 132:469-477.
  • 8Robbiani DF, Colon K, Ely S, et al. Osteopontin dysregulation and lytic bone lesions in multiple myeloma. Hematol Oncol, 2007,25 : 16-20.
  • 9Abe M, Hiura K, Wilde J, et al. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact:a vicious cycle between bone destruction and myeloma expansion. Blood, 2004, 104 : 2484 -2491.

二级参考文献8

  • 1张蕾,陈世伦,陈文明,刘晋伟.多发性骨髓瘤血管内皮生长因子和白细胞介素-6相互作用的研究[J].中华内科杂志,2005,44(2):85-88. 被引量:11
  • 2Choi SJ,Cruz JC,Craig F,et al.Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma.Blood,2000,96:671-675.
  • 3Lentzsch S,Gries M,Janz M,et al.Macrophage inflammatory protein 1-alpha(MIP-1α) triggers migration and singal mediating survival and proliferation in multiple myeloma (MM) cells.Blood,2003,101:3568 -3573.
  • 4Roodman GD,Choi SJ.MIP-1alpha and myeloma bone disease.Cancer Treat Res,2004,118:83-100.
  • 5Oba Y,Lee JW,Ehrlich LA,et al.MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells.Exp Hematol,2005,33:272-278.
  • 6Abe M,Hiura K,Wilde J,et al.Role for macrophage inflammatory protein(MIP) -1 alpha and MIP-1 beta in the development of osteolytic lesions in multiple myeloma.Blood,2002,100:2195-2202.
  • 7Uneda S,Hata H,Matsuno F,et al.Maerophage inflammatory protein 1-alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM.Br J Haematol,2003,120:53-55.
  • 8Oyajobi BO,Franchin G,Williams PJ,et al.Dual effects of macrophage inflammatory protein-1 alpha on osteolysis and tumor burden in the 5TGM1 model of myeloma bone disease.Blood,2003,102:311-319.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部